Hepatomas
3/20/00 (Del Rio)
Group: Monday Residents
RE: A 54 year old African-American male with a 3-week history of jaundice, itching, and dark urine.
Question: What are the characteristics of hepatomas?
Fulltext Available in MDConsult using Journal Search and the search term: 99172836
<1>
Unique Identifier: 99172836
Authors: Molmenti EP. Marsh JW. Dvorchik I. Oliver JH 3rd. Madariaga J. Iwatsuki S.
Institution: Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA. ernestom@baylordallas.com
Title: Hepatobiliary malignancies. Primary hepatic malignant neoplasms. [Review] [32 refs]
Source: Surgical Clinics of North America. 79(1):43-57, viii, 1999 Feb.
Abstract: Primary hepatic tumors are epithelial, mesenchymal, or mixed in origin. Of these, epithelial tumors are the most common and include hepatocellular carcinoma, cholangiocarcinoma, mixed hepatocholangiocarcinoma, hepatoblastoma, and a variety of more rare tumors. Hepatocellular carcinoma, also know as hepatoma or malignant hepatoma, is the most common, followed by cholangiocarcinoma. This article discusses these two malignancies. [References: 32]
Link Directly to Fulltext article in Ovid
<1>
Unique Identifier: 99231450
Authors: Schafer DF. Sorrell MF.
Institution: Department of Internal Medicine, University of Nebraska Medical Center, Omaha 66198-2009, USA.
Title: Hepatocellular carcinoma [see comments]. [Review] [57 refs] Comments Comment in: Lancet 1999 Jul 17;354(9174):253, Comment in: Lancet 1999 Jul 17;354(9174):253-4
Source: Lancet. 353(9160):1253-7, 1999 Apr 10. NLM Journal Code l0s Journal Subset A, C Country of Publication England
Abstract: Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable. Hepatitis B and C exist only in man; the viruses have no known non-human reservoirs. Transmission of the viruses can be interrupted by vaccination against hepatitis B virus infection and improvements in medical techniques for hepatitis C, for which no vaccine has yet been developed.
[litsrch99/footer_generic.html]